Since PSP is characterized by aggregated, insoluble tau in both neurons and glia, especially in subcortical regions, these aggregates might not lead to detectable levels of soluble pTau being released into CSF or blood. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.